These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
396 related articles for article (PubMed ID: 23392430)
1. Quantitative analysis of multiparametric prostate MR images: differentiation between prostate cancer and normal tissue and correlation with Gleason score--a computer-aided diagnosis development study. Peng Y; Jiang Y; Yang C; Brown JB; Antic T; Sethi I; Schmid-Tannwald C; Giger ML; Eggener SE; Oto A Radiology; 2013 Jun; 267(3):787-96. PubMed ID: 23392430 [TBL] [Abstract][Full Text] [Related]
2. Validation of quantitative analysis of multiparametric prostate MR images for prostate cancer detection and aggressiveness assessment: a cross-imager study. Peng Y; Jiang Y; Antic T; Giger ML; Eggener SE; Oto A Radiology; 2014 May; 271(2):461-71. PubMed ID: 24533870 [TBL] [Abstract][Full Text] [Related]
3. Prostate cancer aggressiveness: assessment with whole-lesion histogram analysis of the apparent diffusion coefficient. Donati OF; Mazaheri Y; Afaq A; Vargas HA; Zheng J; Moskowitz CS; Hricak H; Akin O Radiology; 2014 Apr; 271(1):143-52. PubMed ID: 24475824 [TBL] [Abstract][Full Text] [Related]
4. Diffusion-weighted endorectal MR imaging at 3 T for prostate cancer: tumor detection and assessment of aggressiveness. Vargas HA; Akin O; Franiel T; Mazaheri Y; Zheng J; Moskowitz C; Udo K; Eastham J; Hricak H Radiology; 2011 Jun; 259(3):775-84. PubMed ID: 21436085 [TBL] [Abstract][Full Text] [Related]
5. Multiparametric prostate MR imaging with T2-weighted, diffusion-weighted, and dynamic contrast-enhanced sequences: are all pulse sequences necessary to detect locally recurrent prostate cancer after radiation therapy? Donati OF; Jung SI; Vargas HA; Gultekin DH; Zheng J; Moskowitz CS; Hricak H; Zelefsky MJ; Akin O Radiology; 2013 Aug; 268(2):440-50. PubMed ID: 23481164 [TBL] [Abstract][Full Text] [Related]
6. Quantitative Analysis of Prostate Multiparametric MR Images for Detection of Aggressive Prostate Cancer in the Peripheral Zone: A Multiple Imager Study. Hoang Dinh A; Melodelima C; Souchon R; Lehaire J; Bratan F; Mège-Lechevallier F; Ruffion A; Crouzet S; Colombel M; Rouvière O Radiology; 2016 Jul; 280(1):117-27. PubMed ID: 26859255 [TBL] [Abstract][Full Text] [Related]
7. Quantitative Multiparametric MRI Features and PTEN Expression of Peripheral Zone Prostate Cancer: A Pilot Study. McCann SM; Jiang Y; Fan X; Wang J; Antic T; Prior F; VanderWeele D; Oto A AJR Am J Roentgenol; 2016 Mar; 206(3):559-65. PubMed ID: 26901012 [TBL] [Abstract][Full Text] [Related]
8. Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: correlation of quantitative MR parameters with Gleason score and tumor angiogenesis. Oto A; Yang C; Kayhan A; Tretiakova M; Antic T; Schmid-Tannwald C; Eggener S; Karczmar GS; Stadler WM AJR Am J Roentgenol; 2011 Dec; 197(6):1382-90. PubMed ID: 22109293 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer. Roethke MC; Kuder TA; Kuru TH; Fenchel M; Hadaschik BA; Laun FB; Schlemmer HP; Stieltjes B Invest Radiol; 2015 Aug; 50(8):483-9. PubMed ID: 25867657 [TBL] [Abstract][Full Text] [Related]
10. Differentiation of prostate cancer lesions in the Transition Zone by diffusion-weighted MRI. Bao J; Wang X; Hu C; Hou J; Dong F; Guo L Eur J Radiol Open; 2017; 4():123-128. PubMed ID: 29034282 [TBL] [Abstract][Full Text] [Related]
11. Prostate cancer: identification with combined diffusion-weighted MR imaging and 3D 1H MR spectroscopic imaging--correlation with pathologic findings. Mazaheri Y; Shukla-Dave A; Hricak H; Fine SW; Zhang J; Inurrigarro G; Moskowitz CS; Ishill NM; Reuter VE; Touijer K; Zakian KL; Koutcher JA Radiology; 2008 Feb; 246(2):480-8. PubMed ID: 18227542 [TBL] [Abstract][Full Text] [Related]
12. Seminal vesicle invasion in prostate cancer: evaluation by using multiparametric endorectal MR imaging. Soylu FN; Peng Y; Jiang Y; Wang S; Schmid-Tannwald C; Sethi I; Eggener S; Antic T; Oto A Radiology; 2013 Jun; 267(3):797-806. PubMed ID: 23440325 [TBL] [Abstract][Full Text] [Related]
13. Texture features on T2-weighted magnetic resonance imaging: new potential biomarkers for prostate cancer aggressiveness. Vignati A; Mazzetti S; Giannini V; Russo F; Bollito E; Porpiglia F; Stasi M; Regge D Phys Med Biol; 2015 Apr; 60(7):2685-701. PubMed ID: 25768265 [TBL] [Abstract][Full Text] [Related]
14. Multiparametric MRI in detection and staging of prostate cancer. Boesen L Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066 [TBL] [Abstract][Full Text] [Related]
15. Prostate cancer: differentiation of central gland cancer from benign prostatic hyperplasia by using diffusion-weighted and dynamic contrast-enhanced MR imaging. Oto A; Kayhan A; Jiang Y; Tretiakova M; Yang C; Antic T; Dahi F; Shalhav AL; Karczmar G; Stadler WM Radiology; 2010 Dec; 257(3):715-23. PubMed ID: 20843992 [TBL] [Abstract][Full Text] [Related]
16. Prostate cancer: apparent diffusion coefficient map with T2-weighted images for detection--a multireader study. Lim HK; Kim JK; Kim KA; Cho KS Radiology; 2009 Jan; 250(1):145-51. PubMed ID: 19017927 [TBL] [Abstract][Full Text] [Related]
17. Assessment of Prostate Cancer Aggressiveness by Use of the Combination of Quantitative DWI and Dynamic Contrast-Enhanced MRI. Hötker AM; Mazaheri Y; Aras Ö; Zheng J; Moskowitz CS; Gondo T; Matsumoto K; Hricak H; Akin O AJR Am J Roentgenol; 2016 Apr; 206(4):756-63. PubMed ID: 26900904 [TBL] [Abstract][Full Text] [Related]
18. Prostate cancer vs. post-biopsy hemorrhage: diagnosis with T2- and diffusion-weighted imaging. Rosenkrantz AB; Kopec M; Kong X; Melamed J; Dakwar G; Babb JS; Taouli B J Magn Reson Imaging; 2010 Jun; 31(6):1387-94. PubMed ID: 20512891 [TBL] [Abstract][Full Text] [Related]
19. The value of ADC, T2 signal intensity, and a combination of both parameters to assess Gleason score and primary Gleason grades in patients with known prostate cancer. Nowak J; Malzahn U; Baur AD; Reichelt U; Franiel T; Hamm B; Durmus T Acta Radiol; 2016 Jan; 57(1):107-14. PubMed ID: 25505225 [TBL] [Abstract][Full Text] [Related]
20. MRI in the detection of prostate cancer: combined apparent diffusion coefficient, metabolite ratio, and vascular parameters. Riches SF; Payne GS; Morgan VA; Sandhu S; Fisher C; Germuska M; Collins DJ; Thompson A; deSouza NM AJR Am J Roentgenol; 2009 Dec; 193(6):1583-91. PubMed ID: 19933651 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]